{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:18:53Z","timestamp":1779110333770,"version":"3.51.4"},"reference-count":15,"publisher":"The Japanese Society for Medical Mycology","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Mycology Journal"],"published-print":{"date-parts":[[2019]]},"DOI":"10.3314\/mmj.19-00009","type":"journal-article","created":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T17:15:40Z","timestamp":1575047740000},"page":"95-100","source":"Crossref","is-referenced-by-count":11,"title":["Retrospective Survey of Treatment Outcomes of Efinaconazole 10% Solution and Luliconazole 5% Solution for Onychomycosis in Our Facility"],"prefix":"10.3314","volume":"60","author":[{"given":"Harunari","family":"Shimoyama","sequence":"first","affiliation":[{"name":"Department of Dermatology, Teikyo University Mizonokuchi Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Kuwano","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Teikyo University Mizonokuchi Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Sei","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Teikyo University Mizonokuchi Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1842","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Ghannoum MA, Hajjeh RA, Scher R, et al: A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns. J Am Acad Dermatol 43: 641-648, 2000.","DOI":"10.1067\/mjd.2000.107754"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Gupta AK, Jain HC, Lynde CW, Macdonald P, Cooper EA, Summerbell RC: Prevalence and epidemiology of onychomycosis in patients visiting physicians' offices: a multicenter Canadian survey of 15,000 patients. J Am Acad Dermatol 43: 244-248, 2000.","DOI":"10.1067\/mjd.2000.104794"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Shimoyama H, Satoh K, Makimura K, Sei Y: Epidemiological survey of onychomycosis pathogens in Japan by real-time PCR. Med Mycol 57: 675-680, 2018.","DOI":"10.1093\/mmy\/myy096"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Ameen M, Lear JT, Madan V, Mohd Mustapa MF, Richardson M: British Association of Dermatologists' guidelines for the management of onychomycosis 2014. Br J Dermatol 171: 937-58, 2014.","DOI":"10.1111\/bjd.13358"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Seebacher C, Brasch J, Abeck D, Cornely O, Effendy I, Ginter-Hanselmayer G, Haake N, Hamm G, Hipler UC, Hof H, Korting HC, Mayser P, Ruhnke M, Schlacke KH, Tietz HJ: Onychomycosis. J Dtsch Dermatol Ges 5: 61-66, 2007.","DOI":"10.1111\/j.1610-0387.2007.06134.x"},{"key":"6","unstructured":"6) Watanabe S, Mochizuki T, Iozumi K, Katoh T, Sei Y, Mutoh M, Naka W, Nishimoto K, Hiruma M, Matsuda T: Guidelines for diagnosis and treatment of dermatophytosis. Jpn J Dermatol 119: 851-862, 2009."},{"key":"7","unstructured":"7) Sigurgeirsson B, Billstein S, Rantanen T, Ruzicka T, di Fonzo E, Vermeer BJ, Goodfield MJ, Evans EG: L.I.ON. Study: efficacy and tolerability of continuous terbinafine (Lamisil) compared to intermittent itraconazole in the treatment of toenail onychomycosis. Lamisil vs. Itraconazole in Onychomycosis. Br J Dermatol 141 Suppl 56: 5-14, 1999."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Cohen AD, Medvesovsky E, Shalev R, Biton A, Chetov T, Naimer S, Shai A, Vardy DA: An independent comparison of terbinafine and itraconazole in the treatment of toenail onychomycosis. J Dermatolog Treat 14: 237-242, 2003.","DOI":"10.1080\/09546630310017834"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Gupta AK, Paquet M, Simpson F, Tavakkol A: Terbinafine in the treatment of dermatophyte toenail onychomycosis: a meta-analysis of efficacy for continuous and intermittent regimens. J Eur Acad Dermatol Venereol 27: 267-272, 2013.","DOI":"10.1111\/j.1468-3083.2012.04584.x"},{"key":"10","unstructured":"10) Gupta AK, Studholme C: Update on efinaconazole 10% topical solution for the treatment of onychomycosis. Skin Therapy Lett 6: 7-11, 2016."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Watanabe S, Kishida H, Okubo A: Efficacy and safety of luliconazole 5% nail solution for the treatment of onychomycosis: A multicenter, double-blind, randomized phase III study. J Dermatol 44: 753-759, 2017.","DOI":"10.1111\/1346-8138.13816"},{"key":"12","unstructured":"12) Sergeev AY, Gupta AK, Sergeev YV: The scoring clinical index for onychomycosis (SCIO index). Skin Therapy Lett 7: 6-7, 2002."},{"key":"13","doi-asserted-by":"crossref","unstructured":"14) Elewski BE, Rich P, Pollak R, Pariser DM, Watanabe S, Senda H, Ieda C, Smith K, Pillai R, Ramakrishna T, Olin JT: Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies. J Am Acad Dermatol 68: 600-608, 2013.","DOI":"10.1016\/j.jaad.2012.10.013"},{"key":"14","doi-asserted-by":"crossref","unstructured":"15) Burkhart CN, Burkhart CG, Gupta AK: Dermatophytoma: recalcitrance to treatment because of existence of fungal biofilm. J Am Acad Dermatol 47: 629-631, 2002.","DOI":"10.1067\/mjd.2002.124699"},{"key":"15","doi-asserted-by":"crossref","unstructured":"17) Yaemsiri S, Hou N, Slining MM, He K: Growth rate of human fingernails and toenails in healthy American young adults. J Eur Acad Dermatol Venereol 24: 420-423, 2010.","DOI":"10.1111\/j.1468-3083.2009.03426.x"}],"container-title":["Medical Mycology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mmj\/60\/4\/60_19-00009\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T06:16:46Z","timestamp":1575267406000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mmj\/60\/4\/60_19-00009\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.3314\/mmj.19-00009","relation":{},"ISSN":["2185-6486","2186-165X"],"issn-type":[{"value":"2185-6486","type":"print"},{"value":"2186-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}